Dr. Lei Zheng is an oncologist in Baltimore, caring for patients with conditions such as pancreatic cancer and gastrointestinal cancers. Regarded as one of the world’s top clinical specialists in pancreatic cancer, Dr. Zheng receives referrals from around the world.

He is an internationally recognized expert in the tumor microenvironment of pancreatic cancer and in mouse models of pancreatic cancer and preclinical studies of combinational immunotherapies. Dr. Zheng serves as co-director of the Pancreatic Cancer Precision Medicine Center of Excellence Program at the Johns Hopkins School of Medicine.

Dr. Zheng received his undergraduate degree in pre-medicine from Peking University in Beijing. He earned his M.D. at Peking Union Medical College and his Ph.D. in molecular medicine at the University of Texas Health Science Center. He completed his residency at Long Island Jewish Medical Center and performed a fellowship in medical oncology at Johns Hopkins.

He also completed a postdoctoral research fellowship in molecular medicine at the University of Texas Health Science Center and a postdoctoral research fellowship in biochemistry and molecular biology at Rockefeller University. Dr. Zheng joined the Johns Hopkins faculty in 2009.

Dr. Zheng is a NIH-funded researcher who currently holds two R01 grants as a PI, one P50 grant as project leader, seven R01 and one R21 grants as co-investigator and 11 industry-contracts for investigator-initiated preclinical and clinical combinational immunotherapy studies as PI. His research interests include pancreatic cancer biology and translational research; translational immunology and cancer immunotherapy; and the tumor microenvironment.

Dr. Zheng is director of the Multidisciplinary Hepato-Pancreato-Biliary Research Laboratory and the director of the NCI T32 Training Program on Surgical Oncology Research for the Department of Surgery. He holds numerous leadership roles, including chair of the China Advisory Group for the International Affairs Committee of the American Association for Cancer Research and editor-in-chief of the Annals of Pancreatic Cancer. He was recognized at the 45th Anniversary Meeting of the American Pancreas Association with the 2014 Hirshberg Award in Pancreatic Cancer. He has published extensively, including multiple book chapters, and was an editor of the book, Pancreatic Cancer.

Dr. Zheng is a member of several professional organizations, including the Chinese American Hematologist Oncologist Network (CAHON), the International Hepato-Pancreato-Biliary Association (IHPBA) and the American Pancreas Association (APA).

View complete profile